DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Ghaneh P. et al
ESPAC-5F: Four arm, prospective, multicentre, international randomised phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer..
ASCO 2020 Abstract 4505
Access:
We do not assume any responsibility for the contents of the web pages of other providers.